501
Views
19
CrossRef citations to date
0
Altmetric
Review

Biomarkers in hepatocellular carcinoma: an overview

, , , &
Pages 549-558 | Received 26 Sep 2016, Accepted 23 Mar 2017, Published online: 11 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hongda Chen, Yue Zhang, Siwen Li, Ni Li, Yuhan Chen, Bei Zhang, Chunfeng Qu, Huiguo Ding, Jian Huang & Min Dai. (2018) Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma. Cancer Management and Research 10, pages 1947-1958.
Read now
Meiyu Dai, Shan Li & Xue Qin. (2018) Colorectal neoplasia differentially expressed: a long noncoding RNA with an imperative role in cancer. OncoTargets and Therapy 11, pages 3755-3763.
Read now

Articles from other publishers (17)

Shiming Yi, Chunlei Zhang, Ming Li & Jiafeng Wang. (2023) Construction of a Novel Diagnostic Model Based on Ferroptosis-Related Genes for Hepatocellular Carcinoma Using Machine and Deep Learning Methods. Journal of Oncology 2023, pages 1-9.
Crossref
Peng Zhu, Feng Zhang, Weijie Deng & Wenbiao Chen. (2022) Integrative analysis of the characteristic of lipid metabolism-related genes for the prognostic prediction of hepatocellular carcinoma. Medicine 101:39, pages e30695.
Crossref
Lu Bai, Zhao-Xu Yang, Jian-Shan Liu, De-Sheng Wang & Heng-Chao Yu. (2022) Prognostic Significance of CCDC137 Expression and Its Association with Immune Infiltration in Hepatocellular Carcinoma. Disease Markers 2022, pages 1-13.
Crossref
Yumin Qiu, Dan Huang, Yanling Sheng, Jinshi Huang, Nuoya Li, Shouhua Zhang, Zhengdong Hong, Xiangbao Yin & Jinlong Yan. (2021) Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1. Experimental Cell Research 405:1, pages 112646.
Crossref
Yueyue Yang, Jiafei Lin, Susu Guo, Xiangfei Xue, Yikun Wang, Shiyu Qiu, Jiangtao Cui, Lifang Ma, Xiao Zhang & Jiayi Wang. (2020) RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer. Cancer Cell International 20:1.
Crossref
Salwa H. Gomaa, Mona M. Abaza, Hoda A. Elattar, Gamal A. Amin & Doaa M. Elshahawy. (2020) Soluble cluster of differentiation 26/soluble dipeptidyl peptidase-4 and glypican-3 are promising serum biomarkers for the early detection of Hepatitis C virus related hepatocellular carcinoma in Egyptians. Arab Journal of Gastroenterology 21:4, pages 224-232.
Crossref
Xiaobin Chi, Yi Jiang, Yongbiao Chen, Lizhi Lv, Jianwei Chen, Fang Yang, Xiaojin Zhang, Fan Pan & Qiucheng Cai. (2020) microR-505/heterogeneous nuclear ribonucleoprotein M inhibits hepatocellular carcinoma cell proliferation and induces cell apoptosis through the Wnt/β-catenin signaling pathway. Biomarkers in Medicine 14:11, pages 981-996.
Crossref
Lixue Yang, Hui Xue, Yanfu Sun, Lei Zhang, Feng Xue & Ruiliang Ge. (2020) CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling. Cell Death & Disease 11:7.
Crossref
Zhuozhen Lyu, Mingze Ma, Yantian Xu, Xinxing Wang, Yuhua Zhu, WanHua Ren & Tao Li. (2020) Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma. International Journal of Clinical Oncology 25:7, pages 1334-1345.
Crossref
Min Yao, Wenli Sai, Wenjie Zheng, Li Wang, Zhizhen Dong & Dengfu Yao. (2020) Secretory Clusterin as a Novel Molecular-targeted Therapy for Inhibiting Hepatocellular Carcinoma Growth. Current Medicinal Chemistry 27:20, pages 3290-3301.
Crossref
Jin‐Yu Sun, Xiao‐Yu Zhang, Yi‐Zhi Cao, Xiao Zhou, Jian Gu & Xiao‐Xin Mu. (2020) Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 24:10, pages 5438-5445.
Crossref
Jun Han, Min‐lu Han, Hao Xing, Zhen‐li Li, Dao‐yi Yuan, Han Wu, Han Zhang, Ming‐da Wang, Chao Li, Lei Liang, Yan‐yan Song, Ai‐jing Xu, Meng‐chao Wu, Feng Shen, Ying Xie & Tian Yang. (2019) Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma. International Journal of Cancer 146:6, pages 1741-1753.
Crossref
Jianping Sun, Yanan Zhao, Ling Qin, Kang Li, Yan Zhao, Huanqin Sun, Ting Zhang & Yonghong Zhang. (2019) Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes. Frontiers in Oncology 9.
Crossref
Andrew Ofosu, Daryl Ramai, Leon E. Kurtz, Lewis Genuth & Madhavi Reddy. (2018) Metastatic Hepatocellular Carcinoma into the Transverse Colon. Journal of Gastrointestinal Cancer 50:3, pages 644-646.
Crossref
Lipeng Qiu, Han Xu, Mengchen Ji, Dongsheng Shang, Ziwen Lu, Yihang Wu, Zhigang Tu & Hanqing Liu. (2019) Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms. Life Sciences 231, pages 116660.
Crossref
Min Yao, Wenjie Zheng, Li Wang, Miao Fang, Dengfu Yao & Zhizheng Dong. 2018. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment.
Hongliang Liu, Junwen Hu, Hua Pan, Dilai Luo, Mingwen Huang & Wei Xu. (2017) CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination. Digestive Diseases and Sciences 63:1, pages 155-165.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.